Skip to content
Search
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
Investors
Technical Support
Contact Us
Investors
Technical Support
Contact Us
Investors
Contact Us
Investors
Contact Us
Schedule a Meeting
Search
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
source:
Featured
T2 Biosystems’ Candida Auris Test Gets Breakthrough Device Designation
FDA Grants Breakthrough Device Designation for the T2Resistance Panel
New Genomic Tests Aim to Diagnose Deadly Infections Faster
T2 Biosystems Appoints Industry Veteran John Sperzel as CEO
T2 Biosystems appoints new CEO
T2 Biosystems jumps on $69m BARDA deal
Ryan K. Shields, PharmD, MS: T2Candida’s Place in Rational Antifungal Management
WEBINAR: Species ID from sepsis causing pathogens in 3 to 5 hours, days faster than blood culture
T2 Biosystems hosts integrated symposium at ECCMID 2019
FDA Grants Breakthrough Device Designation for the T2Resistance Panel
T2 Biosystems Touts Results from 4 Studies of its T2Dx Diagnostics System
T2 Biosystems wins FDA breakthrough nod for drug resistance blood test
Next
→